Related Experiment Videos

Inhibition of neutrophil chemotaxis by purinoceptor agonists

J G Elferink1, B M de Koster, G J Boonen

  • 1Departments of Medical Biochemistry, Biology, University of Leiden, The Netherlands.

Archives Internationales De Pharmacodynamie Et De Therapie
|May 1, 1992
PubMed

Insights

Adenine nucleotides, including adenosine triphosphate (ATP), inhibit neutrophil chemotaxis. This effect is mediated by P2 purinoceptors, suggesting a novel subtype involved in immune cell migration regulation.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Neutrophil chemotaxis is crucial for immune responses.
  • Purinergic signaling, involving nucleotide receptors, plays a role in cellular communication.

Purpose of the Study:

  • To investigate the inhibitory effects of adenine nucleotides on rabbit neutrophil chemotaxis.
  • To identify the purinoceptor subtype involved in this inhibition.

Main Methods:

  • fMet-Leu-Phe-activated chemotaxis assay using rabbit neutrophils.
  • Testing various adenine nucleotides (ATP, ADP, AMP, adenosine) and other nucleoside triphosphates.
  • Assessing inhibition in the presence of EDTA and Ca2+/Mg2+.
  • Investigating desensitization using ApCpp and evaluating relative nucleotide potency.

Main Results:

  • Adenine nucleotides inhibited neutrophil chemotaxis in a concentration-dependent manner.
  • The order of inhibitory potency was ATP[S] > ATP > ADP > AMP > adenosine.
  • Inhibition was independent of ectonucleotidases and Ca2+ fluxes.
  • Other nucleoside triphosphates also inhibited migration, with specific potency rankings observed.
  • Results suggest involvement of P2 purinoceptors, potentially a novel subtype.

Conclusions:

  • Purinoceptor agonists inhibit neutrophil chemotaxis via P2 purinoceptors.
  • The data indicate a purinoceptor subtype distinct from known P2X and P2Y receptors.

Related Concept Videos